Cardinal Health (NYSE:CAH) Misses Q2 CY2026 Sales Expectations
Cardinal Health (NYSE:CAH) reported Q2 CY2026 revenue of $63.67 billion, up 5.8% year on year but below Wall Street expectations. Non-GAAP adjusted EPS was $2.91, up from $2.08, and beat consensus by 20.2%. The company’s adjusted operating margin was about 1.2%. Shares rose 3.5% to $246.85 after the release.
How this was made
The 30-second read
Why it matters
The key trade signal is a top-line miss paired with an adjusted EPS beat, plus commentary that revenue growth has slowed over the last two years while profitability has remained stable.
Market read
Traders can reassess near-term expectations for healthcare distribution demand and the sustainability of earnings support from buybacks and stable margins.
What to watch
Investors may be underweighting the lack of operating leverage, since adjusted operating margin stayed around 1.2% despite revenue growth.
Background
Cardinal Health is a major healthcare distributor and services provider, and the article centers on its Q2 CY2026 results versus consensus.
Ticker impact
Cardinal Health reported Q2 CY2026 revenue of $63.67B, up 5.8% YoY but below Wall Street expectations, while adjusted EPS beat at $2.91.
Choppy trading risk: downside bias if investors focus on the revenue miss, offset by EPS beat and stable margins.
The article provides a concrete revenue miss versus estimates, plus an adjusted EPS beat and stable adjusted operating margin around 1.2%, which can partially cushion the reaction.
Market effects
Signals continued deceleration risk in healthcare distribution demand, despite resilient earnings supported by cost stability and buybacks.
Primarily US healthcare supply chain sentiment; limited direct regional spillover described.
Global supply-chain framing is mentioned, but no specific international catalyst or guidance detail beyond 12-month expectations.
Counterpoint
The revenue miss may be temporary if the company’s 12-month revenue growth outlook (8.8%) improves, and EPS strength is supported by buybacks and stable margins.
Key entities
- companyCardinal Health
Reported Q2 CY2026 revenue and adjusted EPS, and discussed growth and margin trends.
- executiveJason Hollar
CEO quoted regarding performance and fourth-quarter results.
